Novartis

Sandoz launches EpiPen rival at $250 per two-pack
BioPharma Dive
Fri, 01/18/19 - 09:21 pm
Sandoz
Novartis
EpiPens
Symjepi
Novartis teams up with Oxford researchers to crunch big data into clinical insights
Endpoints
Fri, 01/18/19 - 12:05 am
Novartis
University of Oxford
Vas Narasimhan
machine learning
artificial intelligence
Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard
Forbes
Thu, 01/17/19 - 12:04 am
Novartis
Pharma CEOs
Vas Narasimhan
digital pharma
Massachusetts Initiative Looks at Payment Plans for Novartis' SMA Gene Therapy
BioSpace
Mon, 01/14/19 - 11:55 pm
Massachusetts
Novartis
SMA
gene therapy
Kymriah
FDA Gives Amneal's Generic Alzheimer’s & Parkinson’s Patch a Thumbs-Up
BioSpace
Mon, 01/14/19 - 11:32 am
FDA
Amneal
generics
Novartis
Exelon Patch
Alzheimer's disease
Parkinson's Disease
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Mon, 01/14/19 - 11:11 am
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
NASH Space in Focus in 2019 as Firms Look to Diversify
Yahoo/Zacks.com
Sun, 01/13/19 - 11:32 am
NASH
Gilead Sciences
Merck
Roche
Novartis
Jecure Therapeutics
Pfizer
Celgene
Eli Lilly
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
Biopharma Dive
Fri, 01/11/19 - 08:18 pm
NICE
UK
Amgen
Novartis
migraines
Aimovig
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
Fierce Pharma
Fri, 01/11/19 - 10:25 am
JPMHC 2019
Merck
FDA
M&A
Celgene
Bristol-Myers Squibb
Genevant
IPOs
Eli Lilly
Novartis
GSK
Teva Pharmaceutical
Alexion
Pear Therapeutics
Novartis Defends Itself Against Kickback Allegations from Former Employee
BioSpace
Thu, 01/10/19 - 09:57 am
Novartis
kickbacks
whistleblower lawsuits
breast cancer
Novartis puts AI on the job to help reps say the right things to the right doctors
Fierce Pharma
Wed, 01/9/19 - 07:21 pm
Novartis
digital technology
drug reps
artificial intelligence
Day One of JPM Brings Excitement and Promise for a New Year in Biotech and Pharma
BioSpace
Wed, 01/9/19 - 09:40 am
JPMHC 2019
M&A
Eli Lilly
Loxo Oncology
SAGE Therapeutics
Sanofi
Regeneron
Bristol-Myers Squibb
Celgene
Novartis
Gilead Sciences
In R&D rethink, Novartis ditches part of $2.6B Xencor bispecific pact
Fierce Biotech
Tue, 01/8/19 - 10:31 am
Novartis
Xencor
bispecific antibodies
Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises
Fierce Pharma
Tue, 01/8/19 - 12:38 am
Novartis
Pharma CEOs
CAR-T
Kymriah
Vas Narasimhan
JPMHC 2019
Novartis shares data on discontinued antibiotic research
BioCentury
Thu, 01/3/19 - 11:42 pm
Novartis
R&D
antibiotics
For CAR-T Cancer Fighters in the Real World, Two Roads Diverge
Xconomy
Thu, 01/3/19 - 04:16 pm
cancer
CAR-T
Gilead Sciences
Yescarta
Novartis
Kymriah
Why did Liz Barrett turn her back on a top job at Novartis in exchange for the helm of a biotech you never heard of?
Endpoints
Thu, 01/3/19 - 04:10 pm
Liz Barrett
Novartis
Urogen
Novartis (NVS) Benefits From New Drugs & Key Acquisitions
Yahoo/Zacks.com
Mon, 12/31/18 - 12:13 pm
Novartis
M&A
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
Fri, 12/28/18 - 01:30 pm
breast cancer
lung cancer
AstraZeneca
Tagrisso
Novartis
Gleevec
Tasigna
Bristol-Myers Squibb
Sprycel
Pfizer
Bosulif
Takeda
Iclusig
Big Pharma returning to U.S. price hikes in January after pause
Reuters
Fri, 12/21/18 - 10:20 am
drug pricing
Novartis
Bayer
Donald Trump

Pages